Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'This is Christ-mas': Actor Tim Allen Pushed Back on Original 'The Santa Clauses' Plot in Quest to Explore Holiday's 'Religious' History

Account Closed: Banks and Businesses Cancel Christians: 'I'd Heard of This Happening to Literally Dozens of Groups'

White House Doublespeak: We Won't Tell Apple to Allow AirDrop in China Because They're Private, That's a Different Situation from Us Vowing to Watch Twitter

South Dakota's Kristi Noem Bans TikTok, Warns of Chinese Intelligence Gathering

Pastors Take Charge Combatting 'Drag Queen Story Hour' with the Gospel

Project Veritas Posts Part 2 in Its Exposé of HHS Corruption: 'a Very Wicked Thing'

Project Veritas: Biden's HHS Complicit in Shocking Human Trafficking, Part One

'The Chosen' Added to Netflix and Immediately Soars in Popularity as one of the 'Most Liked' Titles

Hawaii's Mauna Loa Eruption: Stunning Video Shows Lava Spewing, Reaching Heights of 164 Feet into the Air

'Genderfluid' Biden Official Sam Brinton Charged with Stealing a Woman's Luggage

Biden Wants Your Retirement Savings to Go Woke. Here Are 3 Ways to Protect Yourself

'They Brought This On Themselves': DeSantis Fires Back After Disney's Bob Iger Regrets Being 'Dragged' into Parental Rights

School Board Walks Out after Being Confronted with Trans Material by Parents; Meanwhile, Doctors Confirm Dangers of 'Gender-Affirming Care'

Senate Ignores Conservative Concerns, Passes Democrats' Same-Sex 'Marriage' Bill With 12 Republican Votes

'Great Reset in Full Force': Dutch Government Plans to Shut Down Up To 3,000 Farms to Meet EU Green Goals

Disney's 'Strange World' Tanks, Indicates Woke Film Movement Is Failing: 'Why Does Everything Have to Be Sexualized?'

Walmart Shooter's Suicide Note: 'I Failed to Listen to the Groans of the Holy Spirit'

Focus on the Family Blamed for Club Q Shooting Despite Jim Daly Condemnation, Suspect's Non-Binary Identity

Medical Clinic Treating People Injured by COVID Shot Opens in Italy

Christian Organization Wins Legal Battle, Will Be Allowed to Hire Christians